Brazilian 5‑Year‑Old Social Media Star Elis Lima Carneiro Dies After Battling Rare Ageing Condition
Elis Lima Carneiro, a 5‑year‑old Brazilian social media star, died on September 30, 2026, after battling Hutchinson‑Gilford progeria syndrome.

In Brief
- •Elis Lima Carneiro, a 5‑year‑old Brazilian social media star, died on September 30, 2026, after battling Hutchinson‑Gilford progeria syndrome.
- •The family announced her death via Instagram, thanking followers and inviting mourners to her wake in Boa Vista, Brazil.
- •Elis and her twin sister Eloá both have the rare condition, which affects roughly 1 in 4–8 million children worldwide.
- •The family’s Instagram account had amassed over one million followers, using the platform to raise awareness about rare syndromes.
Why It Matters
Elis Lima Carneiro’s death highlights the profound human impact of Hutchinson‑Gilford progeria syndrome, a disease that accelerates aging in children and has no cure. Her family’s public sharing of her journey brought global attention to a condition that affects only a handful of children worldwide, underscoring the power of social media to raise awareness and foster support for rare disease communities.
Key Details
- Age at death
- 5 years
- Date of death
- September 30, 2026
- Condition
- Hutchinson‑Gilford progeria syndrome
- Instagram followers
- over 1 million
- Twin sister
- Eloá Lima Carneiro
- Wake location
- Boa Vista, Brazil
Context & Background
Hutchinson‑Gilford progeria syndrome is an extremely rare genetic disorder that causes rapid aging in children, affecting roughly 1 in 4–8 million worldwide, with no known cure.
Original Reporting & Sources
VNews is an independent briefing product. Original reporting remains credited to the following publishers:
This brief was synthesized automatically using attributed third-party reporting. VNews is a digital news publication produced under the VContent Group brand and operated by Francis Vincent Sunday in Ghana, independent from the publishers cited above. Read our AI Transparency Policy and Editorial & Corrections Policy.